Creating R&D Incentives for Medicines for Neglected Diseases | An Economic Analysis of Parallel Imports, Patents, and Alternative Mechanisms to Stimulate Pharmaceutical Research

Frank M�ller-Langer

ISBN 10: 3834917303 ISBN 13: 9783834917300

Editorial: Gabler Verlag, 2009

Nuevos Taschenbuch

Librer�a: preigu, Osnabr�ck, Alemania Calificaci�n del vendedor: 5 de 5 estrellas

Vendedor de AbeBooks desde 5 de agosto de 2024

Este art�culo en concreto ya no est� disponible.

Ver los art�culos de este vendedor Crear una petici�n para art�culos similares

Ver todos los ejemplares de este libro

Descripci�n

Creating R&D Incentives for Medicines for Neglected Diseases | An Economic Analysis of Parallel Imports, Patents, and Alternative Mechanisms to Stimulate Pharmaceutical Research | Frank M�ller-Langer | Taschenbuch | �konomische Analyse des Rechts | xix | Englisch | 2009 | Gabler Verlag | EAN 9783834917300 | Verantwortliche Person f�r die EU: Springer Gabler in Springer Science + Business Media, Tiergartenstr. 15-17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. N� de ref. del art�culo 101634578

Denunciar este art�culo

Sinopsis:

Virtually no research is targeted at developing medicines for tropical diseases as the expected market returns from R&D into these diseases in the private pharmaceuticals sector are too low. Frank M�ller-Langer addresses the market failure with respect to R&D for medicines for tropical diseases and the lack of short-term access to affordable medicines in poor countries. The author analyzes additional push and pull mechanisms to stimulate R&D for pharmaceutical products alongside patent protection which may help mitigate the problem of those consumers in poor countries who lack access to affordable medicines. Furthermore, he reasons that a global regime of banning parallel trade from low-income countries to high-income countries is desirable from a developing country's perspective.

Acerca del autor: Dr. Frank M�ller-Langer is a research fellow at the Max Planck Institute for Intellectual Property, Competition and Tax Law and academic coordinator of the International Max Research School for Competition and Innovation in Munich. He obtained his doctorate in economics from Hamburg University in 2008.

"Sobre este t�tulo" puede pertenecer a otra edici�n de este libro.

Detalles bibliogr�ficos

T�tulo: Creating R&D Incentives for Medicines for ...
Editorial: Gabler Verlag
A�o de publicaci�n: 2009
Encuadernaci�n: Taschenbuch
Condici�n: Neu

Los mejores resultados en AbeBooks

Imagen del vendedor

Creating R&D Incentives for Medicines for Neglected Diseases

Frank M�ller-Langer

Publicado por Gabler Verlag, 2009

ISBN 10: 3834917303 ISBN 13: 9783834917300

Nuevo Tapa blanda

Impresi�n bajo demanda

Librería: moluna, Greven, Alemania

Calificaci�n del vendedor: 5 de 5 estrellas

Condici�n: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Dr. Frank Mueller-Langer is a research fellow at the Max Planck Institute for Intellectual Property, Competition and Tax Law and academic coordinator of the International Max Research School for Competition and Innovation in Munich. He obtained his doctorate. N� de ref. del art�culo: 5380831

Contactar al vendedor

Comprar nuevo

EUR 92,27

Env�o por EUR 48,99
Se env�a de Alemania a Estados Unidos de America

Cantidad disponible: M�s de 20 disponibles

A�adir al carrito

Imagen de archivo

Creating R&D Incentives for Medicines for Neglected Diseases: An Economic Analysis of Parallel Imports, Patents, and Alternative Mechanisms to . Research (�konomische Analyse des Rechts)

Frank M�ller-Langer

Publicado por Gabler Verlag 2009-07-28, 2009

ISBN 10: 3834917303 ISBN 13: 9783834917300

Nuevo Paperback

Librería: Chiron Media, Wallingford, Reino Unido

Calificaci�n del vendedor: 5 de 5 estrellas

Paperback. Condici�n: New. N� de ref. del art�culo: 6666-IUK-9783834917300

Contactar al vendedor

Comprar nuevo

EUR 105,43

Env�o por EUR 17,90
Se env�a de Reino Unido a Estados Unidos de America

Cantidad disponible: 10 disponibles

A�adir al carrito

Imagen del vendedor

Creating R&D Incentives for Medicines for Neglected Diseases : An Economic Analysis of Parallel Imports, Patents, and Alternative Mechanisms to Stimulate Pharmaceutical Research

Frank M�ller-Langer

Publicado por Gabler Verlag, Gabler Verlag, 2009

ISBN 10: 3834917303 ISBN 13: 9783834917300

Nuevo Taschenbuch

Librería: AHA-BUCH GmbH, Einbeck, Alemania

Calificaci�n del vendedor: 5 de 5 estrellas

Taschenbuch. Condici�n: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book is the revised version of a doctoral thesis written at the Graduiertenkolleg Law and Economics at Hamburg University. It addresses the market failure with respect to R&D for medicines for tropical diseases and the lack of access to affordable medicines in poor countries. Tropical diseases, such as malaria or leishmaniasis, are among the main causes of death and disability in developing countries. Medical scholars have since long argued that medicines for those neglected infectious diseases either do not exist at all or badly need improvement. This neglect has two main reasons. First, tropical diseases virtually do not occur in the rich countries of the Northern Hemisphere where the bulk of new pharmaceutical inventions are made. Second, intellectual property protection in poor countries of the Southern Hemisphere, i. e. patents or copyrights, is often poorly developed. The innovator faces the risk of losing research and development (R&D) costs as imitators can offer generic drugs at marginal costs. Therefore, not much research is targeted at developing medicines for tropical diseases as the expected market returns from R&D in the private pharmaceuticals sector are too low. Frank M�ller-Langer provides a well-researched outline of the legal landscape regarding international patent protection. He focuses on the relevant provisions stated in the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement), which is aimed at harmonizing and strengthening intellectual property protection around the world. N� de ref. del art�culo: 9783834917300

Contactar al vendedor

Comprar nuevo

EUR 106,99

Env�o por EUR 62,33
Se env�a de Alemania a Estados Unidos de America

Cantidad disponible: 1 disponibles

A�adir al carrito

Imagen del vendedor

Creating R&D Incentives for Medicines for Neglected Diseases

Frank M�ller-Langer

Publicado por Gabler, Gabler Verlag Jul 2009, 2009

ISBN 10: 3834917303 ISBN 13: 9783834917300

Nuevo Taschenbuch

Impresi�n bajo demanda

Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania

Calificaci�n del vendedor: 5 de 5 estrellas

Taschenbuch. Condici�n: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book is the revised version of a doctoral thesis written at the Graduiertenkolleg Law and Economics at Hamburg University. It addresses the market failure with respect to R&D for medicines for tropical diseases and the lack of access to affordable medicines in poor countries. Tropical diseases, such as malaria or leishmaniasis, are among the main causes of death and disability in developing countries. Medical scholars have since long argued that medicines for those neglected infectious diseases either do not exist at all or badly need improvement. This neglect has two main reasons. First, tropical diseases virtually do not occur in the rich countries of the Northern Hemisphere where the bulk of new pharmaceutical inventions are made. Second, intellectual property protection in poor countries of the Southern Hemisphere, i. e. patents or copyrights, is often poorly developed. The innovator faces the risk of losing research and development (R&D) costs as imitators can offer generic drugs at marginal costs. Therefore, not much research is targeted at developing medicines for tropical diseases as the expected market returns from R&D in the private pharmaceuticals sector are too low. Frank M�ller-Langer provides a well-researched outline of the legal landscape regarding international patent protection. He focuses on the relevant provisions stated in the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement), which is aimed at harmonizing and strengthening intellectual property protection around the world. 297 pp. Englisch. N� de ref. del art�culo: 9783834917300

Contactar al vendedor

Comprar nuevo

EUR 106,99

Env�o por EUR 23,00
Se env�a de Alemania a Estados Unidos de America

Cantidad disponible: 2 disponibles

A�adir al carrito

Imagen del vendedor

Creating R&D Incentives for Medicines for Neglected Diseases

Frank M�ller-Langer

Publicado por Gabler Verlag, Gabler Verlag Jul 2009, 2009

ISBN 10: 3834917303 ISBN 13: 9783834917300

Nuevo Taschenbuch

Impresi�n bajo demanda

Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania

Calificaci�n del vendedor: 5 de 5 estrellas

Taschenbuch. Condici�n: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Virtually no research is targeted at developing medicines for tropical diseases as the expected market returns from R&D into these diseases in the private pharmaceuticals sector are too low. Frank M�ller-Langer addresses the market failure with respect to R&D for medicines for tropical diseases and the lack of short-term access to affordable medicines in poor countries. The author analyzes additional push and pull mechanisms to stimulate R&D for pharmaceutical products alongside patent protection which may help mitigate the problem of those consumers in poor countries who lack access to affordable medicines. Furthermore, he reasons that a global regime of banning parallel trade from low-income countries to high-income countries is desirable from a developing country's perspective.Gabler, Betriebswirt.-Vlg, Abraham-Lincoln-Str. 46, 65189 Wiesbaden 320 pp. Englisch. N� de ref. del art�culo: 9783834917300

Contactar al vendedor